T2 lesions and rate of progression of disability in multiple sclerosis

被引:25
|
作者
Mostert, J. P. [1 ,2 ]
Koch, M. W. [1 ]
Steen, C. [1 ]
Heersema, D. J. [1 ]
de Groot, J. C. [3 ]
De Keyser, J. [1 ,4 ]
机构
[1] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands
[3] Univ Groningen, Dept Radiol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[4] Free Univ Brussels, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
关键词
disease progression; MRI; multiple sclerosis; prognosis; AXONAL LOSS; INTERFERON BETA-1B; PREDICTIVE-VALUE; MRI; DISEASE; TRIAL; ONSET; PHASE; MS;
D O I
10.1111/j.1468-1331.2010.03093.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients, who were clinically followed. There were 90 patients with progressive MS (35 secondary progressive and 55 primary progressive), and 96 with relapsing remitting MS. The rate of progression of disability was measured by time to sustained progression of disability (defined as an increase in >= 1 point when the Expanded Disability Status Scale (EDSS) was 5.5 or less and an increase in EDSS of >= 0.5 point when the EDSS was 6.0 or higher), and by the Multiple Sclerosis Severity Score (MSSS). Results: During follow-up (median 15 years, IQR 12-17 years), 94% of the patients with progressive MS and 50% of the patients with relapsing remitting MS had progression of disability. Higher T2 lesion number and load were modestly associated with a higher rate of disease progression on the MSSS and a shorter time to progression of disability in relapsing remitting MS, but not in progressive MS. Conclusions: Our findings indicate that the amount of T2 lesions has a small predictive value for progression of disability in relapsing remitting MS, but has no influence on the rate of progression in progressive MS.
引用
收藏
页码:1471 / 1475
页数:5
相关论文
共 50 条
  • [21] Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression
    Treaba, Constantina A.
    Conti, Allegra
    Klawiter, Eric C.
    Barletta, Valeria T.
    Herranz, Elena
    Mehndiratta, Ambica
    Russo, Andrew W.
    Sloane, Jacob A.
    Kinkel, Revere P.
    Toschi, Nicola
    Mainero, Caterina
    BRAIN COMMUNICATIONS, 2021, 3 (03)
  • [22] Influence of CNS T2-focal lesions on cervical cord atrophy and disability in multiple sclerosis
    Pravata, Emanuele
    Valsasina, Paola
    Gobbi, Claudio
    Zecca, Chiara
    Riccitelli, Gianna C.
    Filippi, Massimo
    Rocca, Maria A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (11) : 1402 - 1409
  • [23] MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation
    Bakshi, R
    Shaikh, ZA
    Janardhan, V
    NEUROREPORT, 2000, 11 (01) : 15 - 21
  • [24] Chronic T2 Lesions in Multiple Sclerosis are Heterogeneous Regarding Phase MR Imaging
    S. Siemonsen
    K.L. Young
    M. Bester
    J. Sedlacik
    C. Heesen
    J. Fiehler
    J.-P. Stellmann
    Clinical Neuroradiology, 2016, 26 : 457 - 464
  • [25] Impact of comorbidities on the disability progression in multiple sclerosis
    Maric, Gorica
    Pekmezovic, Tatjana
    Tamas, Olivera
    Veselinovic, Nikola
    Jovanovic, Aleksa
    Lalic, Katarina
    Mesaros, Sarlota
    Drulovic, Jelena
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 24 - 29
  • [26] A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression
    Nakamura, Yuri
    Gaetano, Laura
    Matsushita, Takuya
    Anna, Altermatt
    Sprenger, Till
    Radue, Ernst-Wilhelm
    Wuerfel, Jens
    Bauer, Lorena
    Amann, Michael
    Shinoda, Koji
    Isobe, Noriko
    Yamasaki, Ryo
    Saida, Takahiko
    Kappos, Ludwig
    Kira, Jun-ichi
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [27] Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS
    Tur, C.
    Khaleeli, Z.
    Ciccarelli, O.
    Altmann, D. R.
    Cercignani, M.
    Miller, D. H.
    Thompson, A. J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (04) : 423 - 428
  • [28] Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
    Bonzano, L.
    Roccatagliata, L.
    Mancardi, G. L.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (09) : 1043 - 1047
  • [29] Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patients
    Rovira, Alex
    Corral, Juan Francisco
    Auger, Cristina
    Valverde, Sergi
    Vidal-Jordana, Angela
    Oliver, Arnau
    de Barros, Andrea
    Ng Wong, Yiken Karelys
    Tintore, Mar
    Pareto, Deborah
    Aymerich, Francesc Xavier
    Montalban, Xavier
    Llado, Xavier
    Alonso, Juli
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (08) : 1209 - 1218
  • [30] Long-term disability and progression in spinal onset multiple sclerosis
    Tiftikcioglu, Bedile Irem
    Ilgezdi, Irem
    Zorlu, Yasar
    Sener, Ufuk
    Tokucoglu, Figen
    ACTA NEUROLOGICA BELGICA, 2018, 118 (02) : 217 - 225